It has been found that FKBP1A is up-regulated in prostate cancer and head and neck squamous cell carcinoma, and enhances paclitaxel-resistance and associates with lymph node metastasis [32, 33]. Here, FKBP1A is linked to head and neck squamous cell carcinoma.